Artificial intelligence fully automated analysis of handheld echocardiography in real-world patients with suspected heart failure

Heart Failure

Association of a remote monitoring programme with all-cause mortality and hospitalizations in patients with heart failure: National-scale, real-world evidence from a 3-year propensity score analysis of the TELESAT-HF study

Eur J Heart Fail

Girerd N, Barbet V, Seronde MF, Benchimol H, Jagu A, Tartière JM, Hanon O, Picard F, Lafitte S, Lemaitre M, Pages N, Nisse-Durgeat S, Jourdain P

doi: 10.1002/ejhf.3563

Heart Failure

Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study

Clin Res Cardiol

Ojeda-Fernández L, Torrigiani G, Molteni M, Fortino I, Cimminiello C, Baviera M

doi: 10.1007/s00392-025-02674-9

Heart Failure

Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry

Eur J Heart Fail

Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C

doi: 10.1002/ejhf.3565

Heart Failure

Real-world use of guideline-directed therapy for heart failure: Insights from the Danish Heart Failure Registry

ESC Heart Fail

Schjødt I, Valentin JB, Johnsen SP, Mols RE, Egstrup K, Løgstrup BB

doi: 10.1002/ehf2.15320

Heart Failure

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

Circulation

Berg DD, Patel SM, Haller PM, Cange AL, Palazzolo MG, Bellavia A, Kuder JF, Desai AS, Inzucchi SE, McMurray JJV, O'Meara E, Verma S, Bělohlávek J, Drożdż J, Merkely B, Ogunniyi MO, Drasnar T, Izzo JL, Sarman B, McGinty JE, Ramanathan K, Mulkay AJ, Przybylski A, Ruff CT, O'Donoghue ML, Murphy SA, Sabatine MS, Wiviott SD, DAPA ACT HF-TIMI 68 Trial Committees and Investigators

doi: 10.1161/CIRCULATIONAHA.125.076575

Heart Failure

Prognosis After >50% Decline in eGFR in Heart Failure Patients: A Nationwide Real-World Study

JACC Heart Fail

Anjum DZ, Elmegaard M, Garred CH, Nouhravesh N, Fosbol E, Jhund PS, McMurray JJV, Petrie MC, Køber L, Schou M

doi: 10.1016/j.jchf.2025.02.027

Heart Failure

Predicting Heart Failure Outcomes Using Patient-Reported Health Status: Real-World Validation of the KCCQ-12

J Am Coll Cardiol

El-Sabawi BR, Al-Garadi MA, Steitz BD, Perkins AM, McCoy AB, Sengstack DG, Greevy RA Jr, Burnell EH, Schlendorf KH, Lindenfeld J, Stevenson LW, Gupta DK, Spertus JA, Collins SP, Matheny ME, Bachmann JM

doi: 10.1016/j.jacc.2025.03.545

Heart Failure

Aggregate index of systemic inflammation as a novel prognostic biomarker in Chinese patients with acute decompensated heart failure: a population-based real-world study

Front Endocrinol (Lausanne)

Hu L, Deng Y, Liu C, Kuang Y, Huang X, Zhang J, Huang W, Jian Y, Xie G, Zou Y, Zhang S

doi: 10.3389/fendo.2025.1627821

Heart Failure

The use of echocardiography and echocardiographic findings in patients hospitalized for acute heart failure

ESC Heart Fail

Lorlowhakarn K, Ratchataswan T, Leesutipornchai T, Jaroenlapnopparat A, Waitayangkoon P, Sinphurmsukskul S, Siwamogsatham S, Puwanant S, Songmuang SB, Ariyachaipanich A

doi: 10.1002/ehf2.15268

Related content

Association of a remote monitoring programme with all-cause mortality and hospitalizations in patients with heart failure: National-scale, real-world evidence from a 3-year propensity score analysis of the TELESAT-HF study

Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study

Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry

Real-world use of guideline-directed therapy for heart failure: Insights from the Danish Heart Failure Registry

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

Prognosis After >50% Decline in eGFR in Heart Failure Patients: A Nationwide Real-World Study

Predicting Heart Failure Outcomes Using Patient-Reported Health Status: Real-World Validation of the KCCQ-12

Aggregate index of systemic inflammation as a novel prognostic biomarker in Chinese patients with acute decompensated heart failure: a population-based real-world study

The use of echocardiography and echocardiographic findings in patients hospitalized for acute heart failure